MedTrace Logo

Evidence-Based Neurorehabilitation in Children With CP

NCT03128385 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-03-12

No results posted yet for this study

Summary

This 3-year research project aims to investigate and compare the treatment effectiveness (in terms of motor and psychosocial outcomes) and potential predictors (in terms of demographical, biological and psychosocial domains) of the intensive and distributed Child- and Family-Friendly CIT protocols with an equivalent intervention period in children with CP by quasi randomized controlled study design. In addition, the selection and examination of outcome measures were based on the ICF-CY model to provide comprehensively documents.

Conditions

  • Cerebral Palsy

Interventions

OTHER

Intensive CIT Model Program

Day Camp Model: 1. The treatment was delivered in group-based design, 6 hours a day for 6 days (36 hours in total) 2. constraint of the unaffected hand to encourage the use of the affected hand 3. massed and repetitive practice of the affected hand during the period of constraint 4. use of behavioral techniques termed "shaping" to train the affected hand

OTHER

Distributed CIT Model Program

Home-Based Model: 1. The participants will receive individualized interventions, 2.25 hours a day, two times a week for 8 weeks (36 hours in total). 2. constraint of the unaffected hand to encourage the use of the affected hand 3. massed and repetitive practice of the affected hand during the period of constraint 4. use of behavioral techniques termed "shaping" to train the affected hand

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Tien-Ni Wang · National Taiwan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03128385 on ClinicalTrials.gov